PCN118 Budget IMPACT Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory B-Cell Precursor ACUTE Lymphoblastic Leukemia in the Netherlands
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.255
https://www.valueinhealthjournal.com/article/S1098-3015(20)32511-0/fulltext
Title :
PCN118 Budget IMPACT Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory B-Cell Precursor ACUTE Lymphoblastic Leukemia in the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32511-0&doi=10.1016/j.jval.2020.08.255
First page :
Section Title :
Open access? :
No
Section Order :
10206